Quality of Life Research

, 15:1597 | Cite as

Quality of life in HIV subtype C infection among asymptomatic subjects and its association with CD4 counts and viral loads – a study from South India

  • Prabha S. Chandra
  • Charu Gandhi
  • P. Satishchandra
  • Anupa Kamat
  • Anita Desai
  • V. Ravi
  • Raymond L. Ownby
  • D. K. Subbakrishna
  • Mahendra Kumar



To study the association between quality of life (QOL) domains and biological markers of disease progression of HIV infection, i.e. viral load (VL) and CD4 counts among asymptomatic subjects with HIV subtype C infection in South India.


Quality of life was measured using the locally validated version of the WHOQOL HIV-BREF. The subjects were neurologically asymptomatic, non psychiatrically ill HIV infected men and women participating in a cohort study.


The results indicated mixed findings, with some QOL dimensions being associated with high VLs and low CD4 counts while several others did not show any associations. Significant associations were seen between low CD4 counts and the psychological and social relationships domain, with lower mean scores in these domains being reported by subjects having CD4 counts <200 /mm. However, there were no significant differences between the CD4 subgroups for the domains related to physical health, level of independence, environment, and spirituality domains. Significant lower mean QOL scores were found in the highest VL subgroup compared to other groups for the following WHOQOL HIV-BREF domains: physical, psychological, level of independence, and environmental.


In this sample of HAART naïve asymptomatic HIV infected subjects, some QOL dimensions were associated with the biological markers of disease progression i.e. VL and CD4 counts, while several were not. The associations were significant only in the high VL and low CD4 groups.


CD 4 Counts HIV India Quality of Life Viral load 



This study is supported by an NIH R01 NS-41205 grant from NIH, USA. We acknowledge the support by all the Research Officers and Co-investigators from NIMHANS, Bangalore, India and University of Miami, USA


  1. 1.
    Wilson IB, Cleary PD (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 23:59–65CrossRefGoogle Scholar
  2. 2.
    Wilson IB, Kaplan S (1995) Clinical practice and patients’ health status: How are the two related? Med Care 33:AS209–14PubMedGoogle Scholar
  3. 3.
    O’Keefe EA, Wood R (1996). The impact of human immunodeficiency virus (HIV) infection on quality of life in a multi-cultural South African population. Qual Life Res 5:275–280PubMedCrossRefGoogle Scholar
  4. 4.
    Tsevat J, Solzan JG, Kuntz KM et al. (1996). Health values of patients infected with HIV: Relationship to mental health and physical functioning. Med care 34:44–57PubMedCrossRefGoogle Scholar
  5. 5.
    Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA (1997). Applications of the medical outcomes study health related quality of life measures in HIV/AIDS. Qual Life Res 6:531–534PubMedCrossRefGoogle Scholar
  6. 6.
    Lubeck DP, Fries JF (1997). Assessment of quality of life in early stage HIV-infected persons: Data from AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res 6:494–506PubMedCrossRefGoogle Scholar
  7. 7.
    Siddappa NB, Dash PK, Mahadevan A, Jayasuryan N, Hu F, Dice B, Keefe R, Satish KS, Satish B, Sreekanthan K, Chatterjee R, Venu, K, Satishchandra P, Ravi V, Shankar SK, Shankarappa R, Ranga UJ (2004). Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. Clin Microbiology 42:2742–2751CrossRefGoogle Scholar
  8. 8.
    Mellors JW, Rinaldo CR Jr, Gupta P et al. (1996). Prognosis in HIV-1 infection predicted by the qulity of virus in plasma. Science 7:1167–1170CrossRefGoogle Scholar
  9. 9.
    Mellors JW, Munoz A, Giorgi JV et al. (1997). Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126:946–954PubMedGoogle Scholar
  10. 10.
    O’Brien WA, Hartigan PM, Daar ES, et al. (1997). Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med 126: 939–45PubMedGoogle Scholar
  11. 11.
    Lane HC, Laughon BE, Falloon J, et al. (1994) NIH Conference. Recent advances in the management of AIDS related opportunistic infections. Ann intern Med 120:944–945Google Scholar
  12. 12.
    Macarthur RD, Perez G, Walmsley S, Baxter JD, Mullin CM, Neaton JD. Terry Beirn community programs for clinical research on AIDS (CPCRA) 042/045; Canadian HIV trials network (CTN) 102 protocol teams. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy. HIV Clin Trials 2005; 6: 127–135.Google Scholar
  13. 13.
    Call SA, Kalpo JC, Stewert KE, et al. (2000). Health related quality of life and virologic outcomes in an HIV clinic. Qual Life Res 9:977–85PubMedCrossRefGoogle Scholar
  14. 14.
    Lamping DL (1994). Methods for measuring outcomes to evaluate interventions to improve health related quality of life in HIV infection. Psychol Health 9:31–49Google Scholar
  15. 15.
    Gill CJ, Griffith JL, Jacobson D et al. (2002). Relationship of HIV Viral loads, CD4 counts and HAART use to Health-related Quality of Life. J AIDS 30:485–492Google Scholar
  16. 16.
    Bing EG, Hays RD, Jacobson LP et al. (2000). Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study. Qual Life Res 9:55–63PubMedCrossRefGoogle Scholar
  17. 17.
    Wig N, Lekshmi R, Pal H, Ahuja V, Mittal CM, Agarwal SK (2006). The impact of HIV/AIDS on the quality of life: A cross sectional study in north India. Indian J Med Sci 60:3–12PubMedCrossRefGoogle Scholar
  18. 18.
    Kohli RM, Sane S, Kumar K, Paranjape RS and Mehendele SM (2005). Modification of medical outcome study (MOS) instrument for quality of life assessment & its validation in HIV infected individuals in India. Indian J Med Res 122:297–304PubMedGoogle Scholar
  19. 19.
    Kohli RM, Sane S, Kumar K, Paranjape RS, Mehendele SM (2005). Assessment of quality of life among HIV-infected persons in Pune, India. Qual Life Res 14:1641–1647PubMedCrossRefGoogle Scholar
  20. 20.
    Chandra PS, Deepthi V, Jairam KR, Thomas T (2003). Relationship of psychological morbidity and quality of life to illness-related disclosure among HIV-infected persons. J Psychosom Res 54(3):199–203PubMedCrossRefGoogle Scholar
  21. 21.
    WHOQOL HIV Group (2003). Preliminary development of the World Health Organisation’s Quality of Life HIV instrument (WHOQOL-HIV: Analysis of pilot version. Soc Sci Med 57:1259–75CrossRefGoogle Scholar
  22. 22.
    WHOQOL HIV Group (2004). WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: Results from the field test. AIDS Care 16:882–9CrossRefGoogle Scholar
  23. 23.
    Wing JK, Babor T, Brugha T, et al. (1990). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47(6):589–93PubMedGoogle Scholar
  24. 24.
    Beck AT and Steer RA (1993). Manual for the Beck Depression Inventory. San Antonio, Psychological CorporationGoogle Scholar
  25. 25.
    Chaturvedi SK, Chandra PS, Channabsavanna SM et al. (1994). Detection of Anxiety and Depression in Cancer Patients. NIMHANS J 12(2):141–144Google Scholar
  26. 26.
    Spielberger CD (1984) State-Trait Anxiety Inventory: A Comprehensive Bibliography. Consultant Psychologists Press, Palo Alto, CAGoogle Scholar
  27. 27.
    Saunders JB, Aasland OG, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II.Google Scholar
  28. 28.
    Nieuwkerk PT, Grsolf EH, Colebunders R, et al. (2004). Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus study group. AIDS 14:181–187CrossRefGoogle Scholar
  29. 29.
    Revicki DA, Wu AW, Murray MI (1995). Change in clinical status, health status and health utility outcomes in HIV-infected patients. Med Care 33:AS173–AS182PubMedGoogle Scholar
  30. 30.
    Anastos K, Barron Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Younge M (2004). The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med 140:256–64PubMedGoogle Scholar
  31. 31.
    Burgoyne RW, Roerke SB, Behrens DM, Salit IE (2004). Long-Term Quality of Life outcomes among adults living with HIV in the HAART Era: The interplay of changes in clinical factors and symptom profile. AIDS and Behavior 8(2):151–163PubMedCrossRefGoogle Scholar
  32. 32.
    Weinfurt KP, Willke RJ, Glick HA et al. (2000). Relationship between CD4 count, viral burden and quality of life over time in HIV-1 infected patients. Med care 38:404–410PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • Prabha S. Chandra
    • 1
  • Charu Gandhi
    • 1
  • P. Satishchandra
    • 2
  • Anupa Kamat
    • 3
  • Anita Desai
    • 3
  • V. Ravi
    • 3
  • Raymond L. Ownby
    • 5
  • D. K. Subbakrishna
    • 4
  • Mahendra Kumar
    • 5
  1. 1.Department of PsychiatryNational Institute of Mental Health and Neuro SciencesBangaloreIndia
  2. 2.Department of NeurologyNational Institute of Mental Health and Neuro SciencesBangaloreIndia
  3. 3.Department of NeurovirologyNational Institute of Mental Health and Neuro SciencesBangaloreIndia
  4. 4.Department of Bio-statisticsNational Institute of Mental Health and Neuro SciencesBangaloreIndia
  5. 5.Department of Psychiatry and Behavioral SciencesUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations